To identify novel therapeutic targets for the treatment of peripheral nerve injury, a recent study performs genome-wide CpG methylation profiling and identifies hypermethylation of formin-2 (fmn2) promoter as a key factor that mediates injury responses, microtubule dynamics at the growth cone, and axon regeneration. Here, FMN2 is linked to peripheral nerve injury.